APO RESEARCH · REPORT
Competent Cells
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Product & engineering
Understand the product.
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Selected research
Industry Research
Competent Cells Industry Research Report 2026
Market perspective
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
Read the full market overview
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
Report Scope
This report quantifies the global Competent Cells market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Competent Cells.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Competent Cells Market by Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
Competent Cells Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Competent Cells Segment by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid Creation
Cre-Lox Recombination (PIR1/PIR2)
Competent Cells Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Competent Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Competent Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemically Competent Cells
- Electrocompetent Cells
Applications
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable DNA Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded DNA Production
- Bacmid Creation
- Cre-Lox Recombination (PIR1/PIR2)
Companies covered
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
- GCC Biotech
- SMOBIO Technology
- Edge BioSystems
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Competent Cells by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Chemically Competent Cells
- 2.2.3 Electrocompetent Cells
- 2.3 Competent Cells by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Subcloning & Routine Cloning
- 2.3.3 Phage Display Library Construction
- 2.3.4 Toxic/Unstable DNA Cloning
- 2.3.5 High-Throughput Cloning
- 2.3.6 Protein Expression
- 2.3.7 Mutagenesis
- 2.3.8 Single-Stranded DNA Production
- 2.3.9 Bacmid Creation
- 2.3.10 Cre-Lox Recombination (PIR1/PIR2)
- 2.4 Assumptions and Limitations
3 Competent Cells Breakdown Data by Type
- 3.1 Global Competent Cells Historic Market Size by Type (2021-2026)
- 3.2 Global Competent Cells Forecasted Market Size by Type (2027-2032)
4 Competent Cells Breakdown Data by Application
- 4.1 Global Competent Cells Historic Market Size by Application (2021-2026)
- 4.2 Global Competent Cells Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Competent Cells Market Perspective (2021-2032)
- 5.2 Global Competent Cells Growth Trends by Region
- 5.2.1 Global Competent Cells Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Competent Cells Historic Market Size by Region (2021-2026)
- 5.2.3 Competent Cells Forecasted Market Size by Region (2027-2032)
- 5.3 Competent Cells Market Dynamics
- 5.3.1 Competent Cells Industry Trends
- 5.3.2 Competent Cells Market Drivers
- 5.3.3 Competent Cells Market Challenges
- 5.3.4 Competent Cells Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Competent Cells Players by Revenue
- 6.1.1 Global Top Competent Cells Players by Revenue (2021-2026)
- 6.1.2 Global Competent Cells Revenue Market Share by Players (2021-2026)
- 6.2 Global Competent Cells Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Competent Cells Head Office and Area Served
- 6.4 Global Competent Cells Players, Product Type & Application
- 6.5 Global Competent Cells Manufacturers Established Date
- 6.6 Global Competent Cells Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Competent Cells Market Size (2021-2032)
- 7.2 North America Competent Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Competent Cells Market Size by Country (2021-2026)
- 7.4 North America Competent Cells Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Competent Cells Market Size (2021-2032)
- 8.2 Europe Competent Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Competent Cells Market Size by Country (2021-2026)
- 8.4 Europe Competent Cells Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Competent Cells Market Size (2021-2032)
- 9.2 Asia-Pacific Competent Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Competent Cells Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Competent Cells Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Competent Cells Market Size (2021-2032)
- 10.2 South America Competent Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Competent Cells Market Size by Country (2021-2026)
- 10.4 South America Competent Cells Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Competent Cells Market Size (2021-2032)
- 11.2 Middle East & Africa Competent Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Competent Cells Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Competent Cells Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Merck KGaA
- 12.1.1 Merck KGaA Company Information
- 12.1.2 Merck KGaA Business Overview
- 12.1.3 Merck KGaA Revenue in Competent Cells Business (2021-2026)
- 12.1.4 Merck KGaA Competent Cells Product Portfolio
- 12.1.5 Merck KGaA Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Competent Cells Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Competent Cells Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 Agilent Technologies
- 12.3.1 Agilent Technologies Company Information
- 12.3.2 Agilent Technologies Business Overview
- 12.3.3 Agilent Technologies Revenue in Competent Cells Business (2021-2026)
- 12.3.4 Agilent Technologies Competent Cells Product Portfolio
- 12.3.5 Agilent Technologies Recent Developments
- 12.4 Takara Bio
- 12.4.1 Takara Bio Company Information
- 12.4.2 Takara Bio Business Overview
- 12.4.3 Takara Bio Revenue in Competent Cells Business (2021-2026)
- 12.4.4 Takara Bio Competent Cells Product Portfolio
- 12.4.5 Takara Bio Recent Developments
- 12.5 Promega Corporation
- 12.5.1 Promega Corporation Company Information
- 12.5.2 Promega Corporation Business Overview
- 12.5.3 Promega Corporation Revenue in Competent Cells Business (2021-2026)
- 12.5.4 Promega Corporation Competent Cells Product Portfolio
- 12.5.5 Promega Corporation Recent Developments
- 12.6 Beijing TransGen Biotech
- 12.6.1 Beijing TransGen Biotech Company Information
- 12.6.2 Beijing TransGen Biotech Business Overview
- 12.6.3 Beijing TransGen Biotech Revenue in Competent Cells Business (2021-2026)
- 12.6.4 Beijing TransGen Biotech Competent Cells Product Portfolio
- 12.6.5 Beijing TransGen Biotech Recent Developments
- 12.7 GeneScript Corporation
- 12.7.1 GeneScript Corporation Company Information
- 12.7.2 GeneScript Corporation Business Overview
- 12.7.3 GeneScript Corporation Revenue in Competent Cells Business (2021-2026)
- 12.7.4 GeneScript Corporation Competent Cells Product Portfolio
- 12.7.5 GeneScript Corporation Recent Developments
- 12.8 Yeastern Biotech
- 12.8.1 Yeastern Biotech Company Information
- 12.8.2 Yeastern Biotech Business Overview
- 12.8.3 Yeastern Biotech Revenue in Competent Cells Business (2021-2026)
- 12.8.4 Yeastern Biotech Competent Cells Product Portfolio
- 12.8.5 Yeastern Biotech Recent Developments
- 12.9 New England Biolabs
- 12.9.1 New England Biolabs Company Information
- 12.9.2 New England Biolabs Business Overview
- 12.9.3 New England Biolabs Revenue in Competent Cells Business (2021-2026)
- 12.9.4 New England Biolabs Competent Cells Product Portfolio
- 12.9.5 New England Biolabs Recent Developments
- 12.10 QIAGEN N.V.
- 12.10.1 QIAGEN N.V. Company Information
- 12.10.2 QIAGEN N.V. Business Overview
- 12.10.3 QIAGEN N.V. Revenue in Competent Cells Business (2021-2026)
- 12.10.4 QIAGEN N.V. Competent Cells Product Portfolio
- 12.10.5 QIAGEN N.V. Recent Developments
- 12.11 OriGene Technologies
- 12.11.1 OriGene Technologies Company Information
- 12.11.2 OriGene Technologies Business Overview
- 12.11.3 OriGene Technologies Revenue in Competent Cells Business (2021-2026)
- 12.11.4 OriGene Technologies Competent Cells Product Portfolio
- 12.11.5 OriGene Technologies Recent Developments
- 12.12 Lucigen
- 12.12.1 Lucigen Company Information
- 12.12.2 Lucigen Business Overview
- 12.12.3 Lucigen Revenue in Competent Cells Business (2021-2026)
- 12.12.4 Lucigen Competent Cells Product Portfolio
- 12.12.5 Lucigen Recent Developments
- 12.13 Zymo Research
- 12.13.1 Zymo Research Company Information
- 12.13.2 Zymo Research Business Overview
- 12.13.3 Zymo Research Revenue in Competent Cells Business (2021-2026)
- 12.13.4 Zymo Research Competent Cells Product Portfolio
- 12.13.5 Zymo Research Recent Developments
- 12.14 Bio-Rad Laboratories
- 12.14.1 Bio-Rad Laboratories Company Information
- 12.14.2 Bio-Rad Laboratories Business Overview
- 12.14.3 Bio-Rad Laboratories Revenue in Competent Cells Business (2021-2026)
- 12.14.4 Bio-Rad Laboratories Competent Cells Product Portfolio
- 12.14.5 Bio-Rad Laboratories Recent Developments
- 12.15 Bioline
- 12.15.1 Bioline Company Information
- 12.15.2 Bioline Business Overview
- 12.15.3 Bioline Revenue in Competent Cells Business (2021-2026)
- 12.15.4 Bioline Competent Cells Product Portfolio
- 12.15.5 Bioline Recent Developments
- 12.16 Delphi Genetics
- 12.16.1 Delphi Genetics Company Information
- 12.16.2 Delphi Genetics Business Overview
- 12.16.3 Delphi Genetics Revenue in Competent Cells Business (2021-2026)
- 12.16.4 Delphi Genetics Competent Cells Product Portfolio
- 12.16.5 Delphi Genetics Recent Developments
- 12.17 IBA GmBH
- 12.17.1 IBA GmBH Company Information
- 12.17.2 IBA GmBH Business Overview
- 12.17.3 IBA GmBH Revenue in Competent Cells Business (2021-2026)
- 12.17.4 IBA GmBH Competent Cells Product Portfolio
- 12.17.5 IBA GmBH Recent Developments
- 12.18 Cell Applications
- 12.18.1 Cell Applications Company Information
- 12.18.2 Cell Applications Business Overview
- 12.18.3 Cell Applications Revenue in Competent Cells Business (2021-2026)
- 12.18.4 Cell Applications Competent Cells Product Portfolio
- 12.18.5 Cell Applications Recent Developments
- 12.19 BioDynamics Laboratory
- 12.19.1 BioDynamics Laboratory Company Information
- 12.19.2 BioDynamics Laboratory Business Overview
- 12.19.3 BioDynamics Laboratory Revenue in Competent Cells Business (2021-2026)
- 12.19.4 BioDynamics Laboratory Competent Cells Product Portfolio
- 12.19.5 BioDynamics Laboratory Recent Developments
- 12.20 Scarab Genomics
- 12.20.1 Scarab Genomics Company Information
- 12.20.2 Scarab Genomics Business Overview
- 12.20.3 Scarab Genomics Revenue in Competent Cells Business (2021-2026)
- 12.20.4 Scarab Genomics Competent Cells Product Portfolio
- 12.20.5 Scarab Genomics Recent Developments
- 12.21 GCC Biotech
- 12.21.1 GCC Biotech Company Information
- 12.21.2 GCC Biotech Business Overview
- 12.21.3 GCC Biotech Revenue in Competent Cells Business (2021-2026)
- 12.21.4 GCC Biotech Competent Cells Product Portfolio
- 12.21.5 GCC Biotech Recent Developments
- 12.22 SMOBIO Technology
- 12.22.1 SMOBIO Technology Company Information
- 12.22.2 SMOBIO Technology Business Overview
- 12.22.3 SMOBIO Technology Revenue in Competent Cells Business (2021-2026)
- 12.22.4 SMOBIO Technology Competent Cells Product Portfolio
- 12.22.5 SMOBIO Technology Recent Developments
- 12.23 Edge BioSystems
- 12.23.1 Edge BioSystems Company Information
- 12.23.2 Edge BioSystems Business Overview
- 12.23.3 Edge BioSystems Revenue in Competent Cells Business (2021-2026)
- 12.23.4 Edge BioSystems Competent Cells Product Portfolio
- 12.23.5 Edge BioSystems Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst